Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL; STICH Hypothesis 2 Investigators.
N Engl J Med. 2009 Apr 23;360(17):1705-17.
The STICH trial tested the hypothesis about the superiority in coronary-artery bypass grafting ( CABG ) combined with left ventricular reconstruction compared with CABG alone. The study comprised 1000 patients with symptomatic significant left ventricular systolic dysfunction (LVEF ≤35%), coronary artery disease, dominant anterior akinesia or dyskinesia of left ventricle wall and qualification for surgery revascularization. During 48-month follow-up surgical ventricular reconstruction reduced the left ventricular end systolic volume by 19% versus a 6% reduction in a group with CABG alone, but it was associated with any change in neither exercise tolerance nor outcome (defined as all-cause mortality and hospitalization due to cardiac reasons).
The STICH trial tested the very important hypothesis regarding the beneficial effects of surgical ventricular reconstruction added to standard coronary artery by-pass grafting in patients with ischaemic chronic heart failure. Nevertheless, the results from this large multicenter trial that recruited in total 1000 patients failed to show any additional clinical benefits of such an intervention in the context of improvement of exercise capacity or prognosis. Additional post-hoc analyses are underway in order to test whether specific subgroups of patients could benefit from surgical ventricular reconstruction.
© 2017 European Society of Cardiology. All rights reserved